home / stock / btaff / btaff quote
Last: | $30.82 |
---|---|
Change Percent: | -3.11% |
Open: | $31.84 |
Close: | $30.82 |
High: | $31.84 |
Low: | $30.484 |
Volume: | 53,552 |
Last Trade Date Time: | 05/13/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$30.82 | $31.84 | $30.82 | $31.84 | $30.484 | 53,552 | 05-13-2024 |
$30.88 | $30.12 | $30.88 | $30.88 | $30.12 | 27,510 | 05-10-2024 |
$29.407 | $30 | $29.407 | $30.75 | $29.407 | 2,082 | 05-09-2024 |
$30.1 | $29.29 | $30.1 | $30.2485 | $29.29 | 28,619 | 05-08-2024 |
$29.76 | $30 | $29.76 | $30.11 | $29.76 | 2,560 | 05-07-2024 |
$29.8 | $29.8 | $29.8 | $29.83 | $29.78 | 6,725 | 05-06-2024 |
$28.94 | $29.368 | $28.94 | $30.292 | $28.94 | 2,635 | 05-03-2024 |
$29.83 | $29.55 | $29.83 | $30.44 | $29.55 | 44,665 | 05-02-2024 |
$30.8 | $28.2 | $30.8 | $30.8 | $28.2 | 6,632 | 05-01-2024 |
$29.07 | $28.816 | $29.07 | $29.25 | $28.816 | 1,075 | 04-30-2024 |
$28.862 | $30.194 | $28.862 | $30.194 | $28.862 | 905 | 04-29-2024 |
$28.778 | $30.34 | $28.778 | $30.39 | $28.778 | 1,105 | 04-26-2024 |
$28.968 | $29.182 | $28.968 | $29.28 | $28.968 | 5,927 | 04-25-2024 |
$28.85 | $28.85 | $28.85 | $28.85 | $28.85 | 555 | 04-24-2024 |
$29.19 | $29.31 | $29.19 | $30.54 | $29.19 | 1,422 | 04-23-2024 |
$30.26 | $28.838 | $30.26 | $30.26 | $28.838 | 2,131 | 04-22-2024 |
$28 | $28.23 | $28 | $29.11 | $28 | 1,306 | 04-19-2024 |
$29.44 | $28.25 | $29.44 | $29.44 | $28.25 | 5,683 | 04-18-2024 |
$28.176 | $28.308 | $28.176 | $28.7 | $28.176 | 1,761 | 04-17-2024 |
$28.01 | $28.736 | $28.01 | $29.048 | $28.01 | 2,044 | 04-16-2024 |
News, Short Squeeze, Breakout and More Instantly...
British American Tobacco Plc Company Name:
BTAFF Stock Symbol:
OTCMKTS Market:
The FDA has reportedly ordered Reynolds American to stop selling menthol-flavored versions of its Vuse Alto e-cigarette. Reynolds America...
LONDON , Sept. 12, 2019 /PRNewswire/ -- Kingsley Wheaton , Chief Marketing Officer, British American Tobacco, said: "We welcome the USA's Food & Drug Administration (FDA) shining a spotlight on the important issue of preventing youth access to vapour products and consu...